MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/mr/roac083

Медицинская библиотека · Modern rheumatology · 2023

Long-term safety and efficacy of filgotinib treatment for rheumatoid arthritis in Japanese patients naïve to MTX treatment (FINCH 3).

Atsumi Tatsuya, Tanaka Yoshiya, Matsubara Tsukasa, Amano Koichi, Ishiguro Naoki, Sugiyama Eiji, Yamaoka Kunihiro, Westhovens René, Ching Daniel W T, Messina Osvaldo Daniel, Burmester Gerd R, Genovese Mark, Bartok Beatrix, Pechonkina Alena, Kondo Akira, Yin Zhaoyu, Gong Qi, Tasset Chantal, Takeuchi Tsutomu

Рандомизированное исследованиеСтатьяПеревод в очереди

Аннотация

OBJECTIVES

To evaluate the long-term safety and efficacy of filgotinib (FIL) for Japanese patients with rheumatoid arthritis (RA) and limited/no prior methotrexate (MTX) exposure. We present a Japanese population subanalysis of a global randomised-controlled trial at Week 52 and interim long-term extension (LTE) to Week 48 through June 2020.

METHODS

Patients were randomised to FIL 200 mg plus MTX, FIL 100 mg plus MTX, FIL 200 mg, or MTX for 52 weeks. At completion, eligible patients could enrol in the LTE. Those receiving FIL continued; those receiving MTX were rerandomised (blinded) to FIL 200 or 100 mg upon discontinuation of MTX. After a 4-week washout period, MTX could be re-added.

RESULTS

Adverse event rates at Week 52 and in the LTE to Week 48 were comparable across treatment groups. Week 52 American College of Rheumatology 20% improvement (ACR20) rates were 83% (19/23), 82% (9/11), 75% (9/12), and 76% (19/25) for FIL 200 mg plus MTX, FIL 100 mg plus MTX, FIL 200 mg, and MTX, respectively. Through LTE Week 48, ACR20 rates were maintained.

CONCLUSIONS

In the 56 Japanese patients treated with FIL, efficacy was maintained through Week 52 and beyond, with no increases in the incidence of adverse events.

Для цитирования: Atsumi Tatsuya, Tanaka Yoshiya, Matsubara Tsukasa, Amano Koichi, Ishiguro Naoki, Sugiyama Eiji, Yamaoka Kunihiro, Westhovens René, Ching Daniel W T, Messina Osvaldo Daniel, Burmester Gerd R, Genovese Mark, Bartok Beatrix, Pechonkina Alena, Kondo Akira, Yin Zhaoyu, Gong Qi, Tasset Chantal, Takeuchi Tsutomu. Long-term safety and efficacy of filgotinib treatment for rheumatoid arthritis in Japanese patients naïve to MTX treatment (FINCH 3).. Modern rheumatology. 2023. DOI: 10.1093/mr/roac083.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.